Sean Larman
Analyst
Morgan Stanley
Equibles does not estimate personal net worth.
About Sean Larman
Sean Larman is recorded as Analyst at Morgan Stanley. Sean Larman has spoken on 3 earnings calls and 13 other investor events across 14 companies, most recently for Axsome Therapeutics, Inc. on September 16, 2026. Those appearances were for Axsome Therapeutics, Inc. (AXSM), BEONE MEDICINES LTD., Absci Corp (ABSI), Contineum Therapeutics, Inc. (CTNM), Exelixis, Inc. (EXEL) and 9 other companies. The companies whose calls Sean Larman spoke on are classified in the Healthcare sector.
Sean Larman on recent calls
“For important disclosures before we commence, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com forward slash research disclosures.”
“Before we commence, to make you aware of some important disclosures, please see those disclosures at the Morgan Stanley Research Disclosure website at www.morganstanley.com forward slash research disclosures.”
“I'm the Head of US Mid-Cap Biotech Equity Research at Morgan Stanley, and welcome to Morgan Stanley's Global Healthcare Conference.”
“Before we begin, just to make you aware of some important disclosures, for those disclosures, please visit the Morgan Stanley Disclosure website at www.morganstanley.com forward slash research disclosures.”
“Before we commence, I'll make you aware of some important disclosures.”
Affiliation history
-
Morgan Stanley
Analyst
Transcript header (unverified)
Current
Company network
BEONE MEDICINES LTD.
Biotechnology · Healthcare
ABSI
Biotechnology · Healthcare
EXEL
Biotechnology · Healthcare
Drug Manufacturers - Specialty & Generic · Healthcare
CGON
Biotechnology · Healthcare
IRON
Biotechnology · Healthcare
Recent activity
Show 4 earlier activities
-
-
Earnings call
Q1 2026 Results
BEONE MEDICINES LTD.
-
-
Earnings call
Q4 and Full Year 2025 Results
BEONE MEDICINES LTD.